Sameer A. Greenall

563 total citations
22 papers, 424 citations indexed

About

Sameer A. Greenall is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Sameer A. Greenall has authored 22 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Sameer A. Greenall's work include Glioma Diagnosis and Treatment (12 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer Mechanisms and Therapy (3 papers). Sameer A. Greenall is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer Mechanisms and Therapy (3 papers). Sameer A. Greenall collaborates with scholars based in Australia, United Kingdom and United States. Sameer A. Greenall's co-authors include Terrance G. Johns, Jacqueline F. Donoghue, Timothy E. Adams, Andrew M. Scott, Vinochani Pillay, Naomi W. Court, Nicholas G. Gottardo, Kerrie L. McDonald, Daniel J. Gough and Ian P. Street and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Sameer A. Greenall

20 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sameer A. Greenall Australia 13 203 142 125 91 72 22 424
Lotte Hiddingh United States 8 214 1.1× 203 1.4× 97 0.8× 109 1.2× 88 1.2× 9 523
Maurizia Giai Italy 9 281 1.4× 136 1.0× 103 0.8× 70 0.8× 103 1.4× 13 573
K. Jin Kim United States 6 204 1.0× 140 1.0× 46 0.4× 59 0.6× 58 0.8× 7 375
Khatri Latha United States 14 241 1.2× 179 1.3× 162 1.3× 162 1.8× 70 1.0× 20 579
Curt J. Essenburg United States 9 180 0.9× 149 1.0× 40 0.3× 76 0.8× 106 1.5× 17 413
Dongyin Yu United States 7 498 2.5× 194 1.4× 48 0.4× 151 1.7× 82 1.1× 9 685
Ivana Catacchio Italy 13 310 1.5× 204 1.4× 55 0.4× 84 0.9× 41 0.6× 15 561
Dan Lu China 9 458 2.3× 203 1.4× 35 0.3× 131 1.4× 85 1.2× 16 694
Chunhui Zhou China 10 294 1.4× 158 1.1× 31 0.2× 176 1.9× 72 1.0× 29 564
Zuoyi Jiao China 13 297 1.5× 116 0.8× 32 0.3× 192 2.1× 129 1.8× 41 543

Countries citing papers authored by Sameer A. Greenall

Since Specialization
Citations

This map shows the geographic impact of Sameer A. Greenall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer A. Greenall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer A. Greenall more than expected).

Fields of papers citing papers by Sameer A. Greenall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameer A. Greenall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer A. Greenall. The network helps show where Sameer A. Greenall may publish in the future.

Co-authorship network of co-authors of Sameer A. Greenall

This figure shows the co-authorship network connecting the top 25 collaborators of Sameer A. Greenall. A scholar is included among the top collaborators of Sameer A. Greenall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameer A. Greenall. Sameer A. Greenall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Burton, H., et al.. (2024). CO13 Impact on Health Outcomes and Productive Work of Anti-PD-(L)1 Inhibitors to Treat Early-Stage Cancers in England. Value in Health. 27(12). S17–S17. 1 indexed citations
3.
Greenall, Sameer A., Matthew McKenzie, Olan Dolezal, et al.. (2019). Most clinical anti-EGFR antibodies do not neutralize both wtEGFR and EGFRvIII activation in glioma. Neuro-Oncology. 21(8). 1016–1027. 20 indexed citations
4.
Endersby, Raelene, et al.. (2018). A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors. Neoplasia. 20(5). 432–442. 18 indexed citations
5.
Greenall, Sameer A., Jacqueline F. Donoghue, Terrance G. Johns, & Timothy E. Adams. (2018). Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3. Translational Oncology. 11(4). 971–978. 4 indexed citations
6.
Johns, Terrance G., Sameer A. Greenall, Shengnan Chen, et al.. (2018). DDIS-19. CT-179: AN INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOUR ACTIVITY IN BRAIN CANCER. Neuro-Oncology. 20(suppl_6). vi73–vi73.
7.
Donoghue, Jacqueline F., Sameer A. Greenall, Anthony Longano, et al.. (2018). Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response. Cancers. 10(8). 243–243. 19 indexed citations
8.
Greenall, Sameer A., Timothy E. Adams, & Terrance G. Johns. (2018). Abstract 2514: Most clinically approved anti-EGFR antibodies fail to neutralize EGFRvIII, explaining their lack of efficacy in high-grade glioma. Cancer Research. 78(13_Supplement). 2514–2514. 1 indexed citations
9.
Johns, Terrance G., et al.. (2018). EAPH-16. DISCOVERY OF CT-179: A SMALL MOLECULE INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOR IN PEDIATRIC BRAIN CANCER. Neuro-Oncology. 20(suppl_2). i68–i68. 1 indexed citations
10.
Greenall, Sameer A., Yi Chieh Lim, Camilla B. Mitchell, et al.. (2017). Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma. Oncogenesis. 6(5). e336–e336. 50 indexed citations
11.
Greenall, Sameer A., et al.. (2017). P08.21 Discovery of CT-179--a small molecule inhibitor of the transcription factor OLIG2 with potent anti-tumour activity in high-grade glioma. Neuro-Oncology. 19(suppl_3). iii58–iii59. 1 indexed citations
12.
Greenall, Sameer A. & Terrance G. Johns. (2016). EGFRvIII: the promiscuous mutation. Cell Death Discovery. 2(1). 16049–16049. 14 indexed citations
13.
Greenall, Sameer A., Timothy E. Adams, & Terrance G. Johns. (2016). Incomplete target neutralization by the anti-cancer antibody rilotumumab. mAbs. 8(2). 246–252. 14 indexed citations
14.
Greenall, Sameer A., Jacqueline F. Donoghue, Michelle Van Sinderen, et al.. (2015). EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implications. Oncogene. 34(41). 5277–5287. 41 indexed citations
15.
Greenall, Sameer A., Jacqueline F. Donoghue, Nicholas G. Gottardo, Terrance G. Johns, & Timothy E. Adams. (2014). Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivo.. Oncogene. 34(13). 1658–1666. 22 indexed citations
16.
Nilsson, Ulrika W., Terrance G. Johns, Tu’uhevaha J. Kaitu’u‐Lino, et al.. (2013). Effects of Gefitinib, an Epidermal Growth Factor Receptor Inhibitor, on Human Placental Cell Growth. Obstetrics and Gynecology. 122(4). 737–744. 21 indexed citations
17.
Greenall, Sameer A., Ermanno Gherardi, Zhanqi Liu, et al.. (2012). Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET. PLoS ONE. 7(4). e34658–e34658. 25 indexed citations
18.
Greenall, Sameer A., John D. Bentley, Lesley A. Pearce, et al.. (2012). Biochemical Characterization of Individual Human Glycosylated pro-Insulin-like Growth Factor (IGF)-II and big-IGF-II Isoforms Associated with Cancer. Journal of Biological Chemistry. 288(1). 59–68. 36 indexed citations
19.
Greenall, Sameer A., Scott G. Tyack, Michael A. Johnson, & S. I. Sapats. (2010). Antibody fragments, expressed by a fowl adenovirus vector, are able to neutralize infectious bursal disease virus. Avian Pathology. 39(5). 339–348. 10 indexed citations
20.
Pillay, Vinochani, Jacqueline F. Donoghue, Naomi W. Court, et al.. (2009). The Plasticity of Oncogene Addiction: Implications for Targeted Therapies Directed to Receptor Tyrosine Kinases. Neoplasia. 11(5). 448–IN2. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lotte Hiddingh Breakdown of academic impact, for papers by Maurizia Giai Breakdown of academic impact, for papers by K. Jin Kim Breakdown of academic impact, for papers by Khatri Latha Breakdown of academic impact, for papers by Curt J. Essenburg Breakdown of academic impact, for papers by Dongyin Yu Breakdown of academic impact, for papers by Ivana Catacchio Breakdown of academic impact, for papers by Dan Lu Breakdown of academic impact, for papers by Chunhui Zhou Breakdown of academic impact, for papers by Zuoyi Jiao
Rankless by CCL
2026